In contrast to antagonism of DOR, agonist activation of MOR has also been reported to have salutary activity against AD through several mechanisms (Cui et al., 2011; Wang et al., 2015a; Dhull and Kumar, 2018). This evidence concerns the gene OPRM1 and Alzheimer disease.